Another meta-analysis of ∼80,000 participants in 32 prospective studies identified that high levels of Lp-PLA2 mass and activity are associated with a risk of CHD, stroke and cardiovascular mortality (11). This evidence concerns the gene PLA2G7 and stroke disorder.